PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12830260::ACT034423

TXM-CB3

Evidence text

Paper-level observation

Fig. 2G-H: CB3-treated animals maintained a significantly higher probability of remaining seizure-free across the 84-day period (p < 0.001).
textConfidence: medium

Assay observation

Activity
Other
Subtype
General Toxic
Measure
survival_rate
Comparator
=
Raw observation
significantly higher probability of remaining seizure-free across 84-day period
Normalized measurement
=84
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
ACCPCNH
Standardization
ready simple

Source publication

Thioredoxin-mimetic peptide attenuates epilepsy progression and neurocognitive deficits

Redox Biology · 2026

DOI 10.1016/j.redox.2026.104021 PMC12830260
Parent mention

Related peptide identities

PEPDIA-PLP-000024

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.